Citation Impact
Citing Papers
Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell Carcinoma
2002
High-throughput characterization of protein–protein interactions by reprogramming yeast mating
2017 StandoutNobel
V600E BRAF is associated with disabled feedback inhibition of RAF–MEK signaling and elevated transcriptional output of the pathway
2009
A cryo-ET survey of microtubules and intracellular compartments in mammalian axons
2021
Highly Recurrent TERT Promoter Mutations in Human Melanoma
2013 StandoutScience
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
2004 StandoutScience
Hallucinating symmetric protein assemblies
2022 StandoutScienceNobel
Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels.
2001
Hierarchical design of pseudosymmetric protein nanocages
2024 StandoutNatureNobel
Direct conversion of fibroblasts to functional neurons by defined factors
2010 StandoutNatureNobel
Hierarchical Mechanisms for Direct Reprogramming of Fibroblasts to Neurons
2013 StandoutNobel
Structural, mechanistic and clinical aspects of MRP1
1999
Control of enzyme reactions by a reconfigurable DNA nanovault
2017
Sensitivity of Non-Small-Cell Lung Cancer Cell Lines Established from Patients Treated with Prolonged Infusions of Paclitaxel
2003
Cutaneous Wound Healing
1999 Standout
Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF
1989
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies
2002 Standout
The therapeutic potential of interleukin-6 hyperagonists and antagonists
1997
RIG-I-like receptors: their regulation and roles in RNA sensing
2020
Integrin adhesion receptors in tumor metastasis
2003
Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice
2010
Interleukin-6 in Biology and Medicine
1993
Nonalcoholic Fatty Liver Disease
2002 Standout
Targeting and delivery of platinum-based anticancer drugs
2012
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Leveling of prostate cancer mortality in Western Europe
2004
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection
2005
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
2010 StandoutNature
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Global cancer statistics
2011 Standout
Targeting multidrug resistance in cancer
2006 Standout
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
1998 StandoutNature
Prostate cancer incidence and mortality trends in 37 European countries: An overview
2010
The biology of the P-glycoproteins
1995
Bioengineered protein-based nanocage for drug delivery
2016
Inflammatory Mediators, Cytokines, and Adhesion Molecules in Pulmonary Inflammation and Injury
1996
Synthetic Par polarity induces cytoskeleton asymmetry in unpolarized mammalian cells
2023 StandoutNobel
Human Monocyte Chemoattractant Protein-1 (MCP-1)
1991
Immunity, Inflammation, and Cancer
2010 Standout
A Review of the Antioxidant Mechanisms of Polyphenol Compounds Related to Iron Binding
2009
AUTOCRINE AND PARACRINE REGULATION BY CYTOKINES AND GROWTH FACTORS IN MELANOMA
2000
Organocatalytic Asymmetric Hydrolysis of Epoxides
2014 StandoutNobel
Epoxide hydrolases: their roles and interactions with lipid metabolism
2005
Interleukin-6 in clinical medicine
1991
Atherosclerosis — An Inflammatory Disease
1999 Standout
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
2005 StandoutNature
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Recombinant Human Single Chain Fv Antibodies Recognizing Human Interleukin-6
1998 StandoutNobel
Treatment of skin ulcers with cultured epidermal allografts
1989
Human monocyte chemoattractant protein-1 (MCP-1)
1990
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
1997 Standout
Acute-Phase Proteins and Other Systemic Responses to Inflammation
1999 Standout
Abnormal Acidification of Melanoma Cells Induces Tyrosinase Retention in the Early Secretory Pathway
2002
Cellular localization and functional expression of P‐glycoprotein in rat astrocyte cultures
2004
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Development of Multidrug-Resistance Convertors: Sense or Nonsense?
2000
Mevalonate pathway: A review of clinical and therapeutical implications
2007
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
The effects of lanthanum chloride on proliferation and apoptosis of cervical cancer cells: involvement of let-7a and miR-34a microRNAs
2015
Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood.
1990
Plant Phenolics: Extraction, Analysis and Their Antioxidant and Anticancer Properties
2010 Standout
A trithorax-group complex purified from Saccharomyces cerevisiae is required for methylation of histone H3
2001 StandoutNobel
CD45 regulates signal transduction and lymphocyte activation by specific association with receptor molecules on T or B cells.
1988 StandoutNobel
Symmetry disruption commits vault particles to disassembly
2022
Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.
1992 StandoutNobel
An update on human interleukin-1: From molecular biology to clinical relevance
1985
CD45, an integral membrane protein tyrosine phosphatase. Characterization of enzyme activity.
1990 StandoutNobel
Immuno-Navigator, a batch-corrected coexpression database, reveals cell type-specific gene networks in the immune system
2016 StandoutNobel
SYSTEMIC THERAPY FOR RENAL CELL CARCINOMA
2000
Interleukin-1 and the Pathogenesis of the Acute-Phase Response
1984
Genes and pathways downstream of telomerase in melanoma metastasis
2006 StandoutNobel
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ
2001 StandoutScience
Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signaling
2017 Standout
Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2
1997 StandoutNobel
The Caenorhabditis elegans ARIP-4 DNA helicase couples mitochondrial surveillance to immune, detoxification, and antiviral pathways
2022 StandoutNobel
Purification of human interleukin 1 from human monocyte culture supernatants and identity of thymocyte comitogenic factor, fibroblast-proliferation factor, acute-phase protein-inducing factor, and endogenous pyrogen
1985
Phase III Trial of Interferon Alfa-2a With or Without 13-cis-Retinoic Acid for Patients With Advanced Renal Cell Carcinoma
2000
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
1986 StandoutNobel
DNA origami protection and molecular interfacing through engineered sequence-defined peptoids
2020 StandoutNobel
Interleukin 6: A Multifunctional Cytokine Regulating Immune Reactions and the Acute Phase Protein Response
1990
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
1993 StandoutScience
Cancer Genome Landscapes
2013 StandoutScience
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
2009 StandoutScience
A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels
1998 StandoutNobel
Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
2012 StandoutNobel
Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines.
1987
The Pathogenesis of Atherosclerosis: Atherogenesis and Inflammation
1989
Interleukin-1 Stimulates the Secretion of Hypothalamic Corticotropin-Releasing Factor
1987 StandoutScience
Polyphenols, dietary sources and bioavailability.
2007
Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output.
1992
Interleukin-8 as a Macrophage-Derived Mediator of Angiogenesis
1992 StandoutScience
Identification of C5ades arg and an Anionic Neutrophil-Activating Peptide (ANAP) in Psoriatic Scales
1986
Phorbol 12,13‐dibutyrate enhances lateral redistribution of membrane glycoproteins in human blood lymphocytes
1984
IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance
1996 StandoutScience
Prospective Randomized Trial of Interferon Alfa-2a Plus Vinblastine Versus Vinblastine Alone in Patients With Advanced Renal Cell Cancer
1999
Age-Associated Increased Interleukin-6 Gene Expression, Late-Life Diseases, and Frailty
2000
Works of M. Micksche being referenced
Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition
2008
Expression of the multidrug resistance-associated protein (MRP) and chemoresistance of human non-small-cell lung cancer cells
1997
Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk
2003
Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24)
2007
Anticancer effects of zoledronic acid against human osteosarcoma cells
2006
Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications
2005
Cellular Functions of Vaults and their Involvement in Multidrug Resistance
2006
Resistance against novel anticancer metal compounds: Differences and similarities
2008
Chromosomal imbalances in primary and metastatic melanomas
2003
Anticancer activity of the lanthanum compound [tris(1,10-phenanthroline)lanthanum(III)]trithiocyanate (KP772; FFC24)
2005
Vaults and the major vault protein: Novel roles in signal pathway regulation and immunity
2008
Expression and Functional Activity of the ABC-transporter Proteins P-glycoprotein and Multidrug-resistance Protein 1 in Human Brain Tumor Cells and Astrocytes
2002
The focal adhesion kinase (P125FAK) is constitutively active in human malignant melanoma
2002
Intrinsic MDR‐1 gene and P‐glycoprotein expression in human melanoma cell lines
1994
Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells
1997
Prostate cancer in Austria: impact of prostate-specific antigen test on incidence and mortality
2001
Green tea extract and (−)‐epigallocatechin‐3‐gallate, the major tea catechin, exert oxidant but lack antioxidant activities
2005
P‐Glycoprotein regulates chemosensitivity in early developmental stages of the mouse
1993
Autologous tumor killing and natural cytotoxic activity of tumor-associated macrophages in cancer patients
1985
Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells.
1983
Respiratory Burst Capability of Polymorphonuclear Neutrophils and TNF-α Serum Levels in Relationship to the Development of Septic Syndrome in Critically III Patients
1991
Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity.
1985
Serum proteins and cytokines for prediction of sepsis?
1989
Intrapleural administration of OK432 in cancer patients: Activation of nk cells and reduction of suppressor cells
1983
Phase II Results with Recombinant Interferons: Renal Cell Carcinoma and Malignant Melanoma
1985
IFN-beta2/IL-6 augments the activity of human natural killer cells.
1989
Down-Regulation of Sprouty2 in Non–Small Cell Lung Cancer Contributes to Tumor Malignancy via Extracellular Signal-Regulated Kinase Pathway-Dependent and -Independent Mechanisms
2007
Randomised study using IFN-α versus IFN-α plus coumarin and cimetidine for treatment of advanced renal cell cancer
1995
Differential ways of escape from negative growth control by TGF-β1 in premature and mature melanoma cells
1995